Balchem Co. (NASDAQ:BCPC) Position Increased by ICW Investment Advisors LLC

ICW Investment Advisors LLC raised its position in Balchem Co. (NASDAQ:BCPC) by 2.3% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 11,770 shares of the basic materials company’s stock after purchasing an additional 259 shares during the quarter. ICW Investment Advisors LLC’s holdings in Balchem were worth $1,587,000 at the end of the most recent quarter.

Other hedge funds also recently bought and sold shares of the company. BlackRock Inc. raised its holdings in shares of Balchem by 1.0% during the 1st quarter. BlackRock Inc. now owns 4,890,972 shares of the basic materials company’s stock valued at $668,595,000 after purchasing an additional 46,959 shares in the last quarter. Vanguard Group Inc. boosted its stake in shares of Balchem by 7.3% during the 3rd quarter. Vanguard Group Inc. now owns 3,862,027 shares of the basic materials company’s stock worth $469,545,000 after acquiring an additional 261,534 shares in the last quarter. Wasatch Advisors LP increased its holdings in shares of Balchem by 27.0% during the 1st quarter. Wasatch Advisors LP now owns 2,069,516 shares of the basic materials company’s stock valued at $261,752,000 after acquiring an additional 439,827 shares during the last quarter. State Street Corp raised its stake in shares of Balchem by 2.1% in the 1st quarter. State Street Corp now owns 1,086,050 shares of the basic materials company’s stock valued at $137,364,000 after acquiring an additional 22,112 shares in the last quarter. Finally, Conestoga Capital Advisors LLC lifted its stake in shares of Balchem by 0.5% in the second quarter. Conestoga Capital Advisors LLC now owns 1,054,722 shares of the basic materials company’s stock worth $142,187,000 after buying an additional 5,276 shares during the last quarter. 87.91% of the stock is owned by institutional investors and hedge funds.

Balchem Stock Performance

Shares of NASDAQ:BCPC remained flat at $118.31 on Monday. 6,105 shares of the stock traded hands, compared to its average volume of 91,431. The company has a debt-to-equity ratio of 0.39, a current ratio of 3.16 and a quick ratio of 2.08. The firm’s 50 day moving average price is $125.31 and its 200 day moving average price is $129.47. Balchem Co. has a one year low of $110.74 and a one year high of $143.74. The stock has a market capitalization of $3.81 billion, a price-to-earnings ratio of 37.09, a price-to-earnings-growth ratio of 4.34 and a beta of 0.68.

Balchem Cuts Dividend

The company also recently declared an annual dividend, which will be paid on Tuesday, January 16th. Shareholders of record on Friday, December 29th will be issued a $0.398 dividend. The ex-dividend date is Thursday, December 28th. This represents a yield of 0.32%. Balchem’s dividend payout ratio (DPR) is 22.26%.

Insiders Place Their Bets

In other news, Director David B. Fischer sold 3,800 shares of the business’s stock in a transaction that occurred on Monday, September 11th. The stock was sold at an average price of $131.57, for a total transaction of $499,966.00. Following the sale, the director now directly owns 13,469 shares in the company, valued at $1,772,116.33. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Corporate insiders own 1.77% of the company’s stock.

Analyst Ratings Changes

Several equities analysts recently weighed in on BCPC shares. StockNews.com began coverage on Balchem in a research report on Thursday, October 5th. They set a “hold” rating for the company. HC Wainwright cut their price target on Balchem from $165.00 to $135.00 and set a “buy” rating for the company in a report on Monday, October 30th.

Balchem Company Profile

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.